---

Patient: Mr. Mallesh | 56-year-old Male

---

Lab Results Summary

---

Diagnosis: Graves' Disease (Primary Autoimmune Hyperthyroidism)

1. Biochemical hyperthyroidism: Dramatically elevated T3/T4 with completely suppressed TSH
2. Markedly elevated TRAb (27.30 IU/L vs <1.75): This is the pathognomonic finding — thyroid-stimulating immunoglobulins (TSI) bind the TSH receptor and drive autonomous thyroid hormone overproduction. A TRAb >5× the upper limit strongly confirms Graves' disease
3. Anti-TPO normal (21.63): This makes Hashimoto's thyroiditis unlikely as the primary cause
4. Bilateral thyromegaly (diffuse goitre): Classic feature of Graves' disease
5. Multiple cystic foci: Likely colloid nodules within the goitre; USG advises MRI for further evaluation

The elevated indirect bilirubin (0.9 mg/dL) may reflect mild haemolysis or accelerated RBC breakdown seen in thyrotoxicosis.

---

Current Treatment (as written)

---

Analysis of Prescribed Treatment

What is Appropriate ✅

• Carbimazole 10 mg TID (30 mg/day): Correct first-line antithyroid drug for Graves' disease. Harrison's 22e states the initial dose is typically 10–20 mg every 12 hours; 10 mg TID (30 mg/day) is within appropriate range for the degree of thyrotoxicosis seen here. It inhibits TPO and also reduces thyroid antibody levels.
• Propranolol 40 mg BD: Correct use of a beta-blocker to control adrenergic symptoms (palpitations, tremor, anxiety, tachycardia). Propranolol also slightly inhibits T4→T3 peripheral conversion.
• Ferrous Ascorbate + Vitamin C: Appropriate for the mild normocytic anaemia (Hb 11.2). Iron with ascorbic acid improves absorption.
• Vitamin D3 weekly: Indicated — hyperthyroidism causes accelerated bone resorption; ALP is elevated, supporting bone involvement.
• Protein powder: Hyperthyroidism causes catabolism and muscle wasting; protein supplementation is appropriate.
• Rabeprazole + Domperidone (PPI + prokinetic): Reasonable gastroprotection given multiple medications.

Points to Note / Potential Changes Needed ⚠️

1. Carbimazole dose monitoring: At 30 mg/day with this level of T3/T4 elevation, thyroid function tests must be rechecked at 4–6 weeks. The dose should be titrated down once euthyroidism approaches. TSH will remain suppressed for months — use free T4 as the index of response.
2. ALP is significantly elevated (211 U/L): With normal GGT and normal transaminases, this is most likely bone-origin ALP from thyrotoxic osteopathy — not liver disease. Bone-specific ALP and a DEXA scan should be considered to assess bone mineral density.
3. Platelet count (1,22,000): Slightly below normal. Important: Carbimazole can rarely cause agranulocytosis (most serious) and thrombocytopenia. A baseline CBC has been done — this should be repeated at 2–4 weeks and the patient should be counselled to report immediately if fever, sore throat, or unusual bleeding occurs.
4. TRAb markedly elevated (27.30 IU/L): This level is strongly positive. TRAb should be remeasured after 12–18 months of antithyroid therapy to assess likelihood of remission vs need for definitive therapy (radioiodine ¹³¹I or thyroidectomy). High TRAb levels predict a lower chance of drug-induced remission.
5. MRI neck recommended: USG has flagged bilateral thyromegaly with multiple cystic foci and advised MRI for further evaluation. This should be done to exclude any suspicious nodule requiring FNAC.
6. Cetirizine: Likely prescribed for urticaria/pruritus which can accompany Graves' disease or carbimazole. Watch for cross-reactivity if rash occurs (minor rash with carbimazole — can switch to propylthiouracil; severe rash — stop drug).
7. Consider checking: Calcium, Vitamin D level, bone-specific ALP, and serum potassium (hypokalemic periodic paralysis is a rare but recognised complication of thyrotoxicosis, especially in Asian males).

---

Key Monitoring Plan

---

Sources: Harrison's Principles of Internal Medicine 22E (2025), Chapter on Thyroid Disease (Graves' Disease treatment section); Tietz Textbook of Laboratory Medicine 7th Ed; Henry's Clinical Diagnosis and Management by Laboratory Methods